Qingdao NovelBeam TechnologyLtd Past Earnings Performance
Past criteria checks 2/6
Qingdao NovelBeam TechnologyLtd has been growing earnings at an average annual rate of 12.9%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 15.6% per year. Qingdao NovelBeam TechnologyLtd's return on equity is 9.6%, and it has net margins of 30.2%.
Key information
12.9%
Earnings growth rate
7.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 15.6% |
| Return on equity | 9.6% |
| Net Margin | 30.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
There Are Reasons To Feel Uneasy About Qingdao NovelBeam TechnologyLtd's (SHSE:688677) Returns On Capital
Nov 17
Further Upside For Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) Shares Could Introduce Price Risks After 41% Bounce
Oct 08Some Investors May Be Worried About Qingdao NovelBeam TechnologyLtd's (SHSE:688677) Returns On Capital
Jul 03The Price Is Right For Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) Even After Diving 26%
Apr 25Qingdao NovelBeam TechnologyLtd (SHSE:688677) Will Want To Turn Around Its Return Trends
Apr 02Revenue & Expenses Breakdown
How Qingdao NovelBeam TechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 413 | 125 | 73 | 59 |
| 30 Jun 24 | 423 | 127 | 72 | 62 |
| 31 Mar 24 | 440 | 136 | 68 | 64 |
| 31 Dec 23 | 471 | 146 | 69 | 66 |
| 30 Sep 23 | 513 | 161 | 68 | 73 |
| 30 Jun 23 | 548 | 192 | 65 | 70 |
| 31 Mar 23 | 532 | 195 | 63 | 66 |
| 31 Dec 22 | 477 | 183 | 58 | 60 |
| 30 Sep 22 | 431 | 166 | 50 | 55 |
| 30 Jun 22 | 370 | 139 | 46 | 49 |
| 31 Mar 22 | 336 | 127 | 45 | 45 |
| 31 Dec 21 | 310 | 118 | 43 | 41 |
| 30 Sep 21 | 294 | 113 | 40 | 39 |
| 30 Jun 21 | 276 | 105 | 36 | 35 |
| 31 Mar 21 | 271 | 92 | 35 | 34 |
| 31 Dec 20 | 275 | 96 | 32 | 31 |
| 30 Sep 20 | 259 | 89 | 34 | 28 |
| 31 Dec 19 | 253 | 72 | 33 | 29 |
| 31 Dec 18 | 201 | 55 | 27 | 22 |
| 30 Jun 18 | 166 | 39 | 39 | -4 |
| 31 Mar 18 | 176 | 48 | 39 | 0 |
| 31 Dec 17 | 181 | 51 | 23 | 16 |
| 30 Sep 17 | 169 | 48 | 37 | 0 |
| 30 Jun 17 | 159 | 46 | 21 | 12 |
| 31 Dec 16 | 139 | 33 | 38 | 0 |
| 30 Sep 16 | 129 | 30 | 37 | 0 |
| 30 Jun 16 | 119 | 27 | 36 | 0 |
| 31 Mar 16 | 97 | 21 | 29 | 0 |
| 31 Dec 15 | 74 | 16 | 21 | 0 |
| 31 Dec 14 | 68 | 7 | 18 | 0 |
| 31 Dec 13 | 52 | -1 | 17 | 0 |
Quality Earnings: 688677 has high quality earnings.
Growing Profit Margin: 688677's current net profit margins (30.2%) are lower than last year (31.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688677's earnings have grown by 12.9% per year over the past 5 years.
Accelerating Growth: 688677's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688677 had negative earnings growth (-22.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688677's Return on Equity (9.6%) is considered low.